Endocrine Metabolic & Immune Disorders - Drug Targets,
Год журнала:
2022,
Номер
22(13), С. 1276 - 1292
Опубликована: Апрель 7, 2022
Background:
Typical
lung
diseases
are
pneumonia,
asthma,
sleep
apnea
syndrome
(SA),
interstitial
pneumonia
(IP),
cancer,
and
chronic
obstructive
pulmonary
disease
(COPD).
Coronavirus
2019
(COVID-19)
is
a
type
of
viral
pneumonia.
Many
researchers
have
reported
that
phytochemicals
(chemical
compounds
produced
by
plants)
vitamin
D
useful
in
stimulating
our
immunity.
This
review
discusses
the
alleviation
grape
D.
Discussion:
Pneumonia
an
acute
inflammation
caused
infection
pathogens;
worst
case
fatal
cytokine
storm
lung.
In
allergens,
tobacco
smoke,
or
air
pollution
may
cause
seizures.
Lung
fibrosis
manifest
inflammation,
progress
into
alveolar
fibrosis,
respiratory
malfunction.
SA
lifestyle
related
to
obesity
metabolic
syndrome.
To
alleviate
these
symptoms,
changing
eating
habit
one
strategies.
Improvement
daily
reduces
risk
cancer.
Self-management,
including
nutritional
management
exercise,
very
important
for
COPD
patients
addition
pharmacotherapy.
Conclusion:
The
intake
prevents
diseases.
Both
prevent
production
proinflammatory
cytokine,
TNF-α,
responsible
Daily
important.
optimum
level
serum
>
30
ng/mL.
For
prevention
diseases,
upregulating
immunity
maintaining
good
gut
microbiota
because
change
depending
on
what
we
eat.
Journal of Agricultural and Food Chemistry,
Год журнала:
2021,
Номер
69(47), С. 14176 - 14191
Опубликована: Ноя. 16, 2021
Nonalcoholic
fatty
liver
disease
(NAFLD)
is
strongly
associated
with
type
2
diabetes
mellitus
(T2DM).
Sesquiterpene
glycosides
from
loquat
leaf
achieved
beneficial
effects
on
metabolic
syndromes
such
as
NAFLD
and
diabetes;
however,
their
specific
activity
underlying
mechanism
T2DM-associated
have
not
yet
been
fully
understood.
In
the
present
study,
we
found
that
sesquiterpene
glycoside
3
(SG3),
a
novel
isolated
leaf,
was
able
to
prevent
insulin
resistance
(IR),
oxidative
stress,
inflammation.
db/db
mice,
SG3
administration
(25
50
mg/kg/day)
inhibited
obesity,
hyperglycemia,
release
of
inflammatory
cytokines.
(5
10
μM)
also
significantly
alleviated
hepatic
lipid
accumulation,
response
induced
by
high
glucose
combined
oleic
acid
in
HepG2
cells.
Western
blotting
analysis
showed
these
were
related
repair
abnormal
signaling
inhibit
cytochrome
P450
2E1
(CYP2E1)
NOD-like
receptor
family
pyrin
domain-containing
(NLRP3),
both
vivo
vitro.
addition,
treatment
could
decrease
ratio
Firmicutes/Bacteroidetes
increase
relative
abundance
Lachnospiraceae,
Muribaculaceae,
Lactobacillaceae
after
high-throughput
pyrosequencing
16S
rRNA
observe
changes
gut
microbial
composition
mice.
These
findings
proved
protect
against
T2DM
improving
IR,
inflammation
through
regulating
inhibiting
CYP2E1/NLRP3
pathways,
remodeling
mouse
microbiome.
It
suggested
be
considered
new
functional
additive
for
healthy
diet.
European Respiratory Review,
Год журнала:
2022,
Номер
31(164), С. 220028 - 220028
Опубликована: Июнь 14, 2022
COPD
is
predicted
to
become
the
third
leading
cause
of
morbidity
and
mortality
worldwide
by
2030.
Cigarette
smoking
(active
or
passive)
one
its
chief
causes,
with
about
20%
cigarette
smokers
developing
from
smoke
(CS)-induced
irreversible
damage
sustained
inflammation
airway
epithelium.
Inflammasome
activation
leads
cleavage
pro-interleukin
(IL)-1β
pro-IL-18,
along
release
pro-inflammatory
cytokines
via
gasdermin
D
N-terminal
fragment
membrane
pores,
which
further
triggers
acute
phase
responses
concurrent
pyroptosis.
There
currently
intense
interest
in
role
nucleotide-binding
oligomerisation
domain-like
receptor
family,
pyrin
domain
containing
protein-3
inflammasomes
chronic
inflammatory
lung
diseases
such
as
their
potential
for
therapeutic
targeting.
Phytochemicals
including
polyphenols
flavonoids
have
phyto-medicinal
benefits
CS-COPD.
Here,
we
review
published
articles
last
decade
regarding
known
associations
between
inflammasome-mediated
ameliorations
pre-clinical
manifestations
CS-COPD
polyphenol
flavonoid
treatment,
a
focus
on
underlying
mechanistic
insights.
This
article
will
potentially
assist
development
drugs
prevention
therapy
COPD,
particularly
smokers.
Biomedicine & Pharmacotherapy,
Год журнала:
2022,
Номер
149, С. 112823 - 112823
Опубликована: Март 23, 2022
Chronic
obstructive
pulmonary
disease
(COPD)
is
a
prevalent
respiratory
disease.
Aiming
at
assessing
the
effect
of
total
saponins
from
American
ginseng
on
COPD,
both
chemical
composition
and
anti-COPD
activity
wild-simulated
(TSW)
field-grown
(TSF)
were
investigated
in
this
study.
Firstly,
HPLC-ELSD
chromatographic
method
was
established
to
simultaneously
determine
contents
22
TSW
TSF.
Secondly,
CS-induced
COPD
mouse
model
evaluate
The
results
indicated
that
TSF
had
protective
against
by
alleviating
oxidative
stress
inflammatory
response.
showed
stronger
than
Thirdly,
an
integrated
approach
involving
metabolomics
network
pharmacology
used
construct
"biomarker-reaction-enzyme-target"
correlation
aiming
further
exploring
observed
effects.
As
results,
15
biomarkers,
9
targets
5
pathways
identified
play
vital
roles
treatment
COPD.
Fourthly,
based
CS-stimulated
A549
cell
model,
ginsenoside
Rgl,
Rc,
oleanolic
acid,
notoginsenoside
R1,
Fe,
silphioside
B
certified
be
material
basis
for
Finally,
molecular
docking
performed
visualize
binding
modes.
Our
findings
suggested
could
effectively
ameliorate
progression
might
European Respiratory Journal,
Год журнала:
2022,
Номер
60(2), С. 2102604 - 2102604
Опубликована: Янв. 20, 2022
Introduction
Higher
flavonoid
intakes
are
beneficially
associated
with
pulmonary
function
parameters;
however,
their
association
chronic
obstructive
disease
(COPD)
is
unknown.
This
study
aimed
to
examine
associations
between
of
1)
total
flavonoids,
2)
subclasses
and
3)
major
compounds
incident
COPD
in
participants
from
the
Danish
Diet,
Cancer
Health
study.
Methods
prospective
cohort
included
55
413
men
women
without
COPD,
aged
50–65
years
at
recruitment.
Habitual
baseline
were
estimated
a
food
frequency
questionnaire
using
Phenol-Explorer.
nationwide
registers
used
identify
cases
COPD.
Associations
modelled
restricted
cubic
splines
within
Cox
proportional
hazards
models.
Results
During
23
follow-up,
5557
diagnosed
Of
these,
4013
current
smokers,
1062
former
smokers
482
never-smokers.
After
multivariable
adjustments,
highest
had
20%
lower
risk
than
those
lowest
(quintile
5
versus
quintile
1:
HR
0.80,
95%
CI
0.74–0.87);
6–22%
was
observed
for
each
subclass.
The
inverse
intake
present
both
but
only
(HR
0.77,
0.70–0.84)
0.82,
0.69–0.97),
not
Furthermore,
higher
appeared
lessen,
negate,
smoking
intensity.
Conclusion
Dietary
flavonoids
may
be
important
partially
mitigating
smoking-related
However,
cessation
should
remain
priority.
Food Bioscience,
Год журнала:
2024,
Номер
58, С. 103761 - 103761
Опубликована: Фев. 16, 2024
Chronic
obstructive
pulmonary
disease
(COPD)
is
a
widespread
global
health
problem
marked
by
increasing
airflow
limitation
and
chronic
airway
inflammation.
Conventional
treatments
for
COPD
offer
limited
efficacy
have
potentially
undesirable
effects,
requiring
the
investigation
of
other
therapeutic
options.
Because
their
anti-inflammatory,
antioxidant,
bronchodilatory
plant-based
chemicals
emerged
as
viable
candidates
therapy.
The
successful
delivery
these
compounds
to
respiratory
system,
on
hand,
remains
an
enormous
challenge.
This
extensive
review
article
explores
promising
potential
therapies
investigates
leading-edge
nanoformulation
technologies
targeted
at
addressing
complex
challenges
that
accompany
natural
compounds.
We
discuss
multiple
plant-derived
(polyphenols,
flavonoids,
alkaloids)
modes
action
in
reducing
COPD-related
indications
complications.
Additionally,
function
nanotechnology
improving
bioavailability,
stability,
pharmaceuticals
treatment
explored.
Nanoformulation
techniques,
such
nanoparticles,
liposomes,
micelles,
are
described,
with
emphasis
precisely
encapsulate
transport
bioactive
afflicted
parts
lung.
Furthermore,
constraints
development
nanoformulations
also
highlighted,
including
safety,
scalability,
regulatory
issues.
current
aims
provide
thorough
understanding
future
combining
knowledge
novel
technologies.
intersection
nature-inspired
medicines
may
hold
key
more
effective,
safer,
patient-centred
choices
people
suffering
from
this
illness.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(19), С. 10234 - 10234
Опубликована: Сен. 24, 2024
Respiratory
diseases
(RDs)
constitute
a
common
public
health
problem
both
in
industrialized
and
developing
countries.
The
comprehension
of
the
pathophysiological
mechanisms
underlying
these
conditions
development
new
therapeutic
strategies
are
critical
for
improving
quality
life
affected
patients.
β2-adrenergic
receptor
(β2AR)
transient
potential
vanilloid
1
(TRPV1)
involved
physiological
responses
airways.
β2AR
is
implicated
bronchodilation,
mucociliary
clearance,
anti-inflammatory
effects,
while
TRPV1
mediation
pain
cough
reflexes.
In
RDs,
such
as
respiratory
infections,
asthma,
chronic
obstructive
pulmonary
disease
(COPD),
cystic
fibrosis,
concentration
expression
receptors
can
be
altered,
leading
to
significant
consequences.
this
review,
we
provided
an
update
on
literature
about
role
conditions.
We
reported
how
diminished
or
defective
during
viral
infections
prolonged
therapy
with
β2-agonists
increase
severity
pathologies
impact
prognosis.
Conversely,
was
pivotal
neuroinflammation,
its
modulation
could
lead
innovative
treatment
specific
indicate
future
perspectives
personalized
treatments
RDs
through
comprehensive
analysis
roles
pathological
pathologies.